UBS Call 278 MDO 16.01.2026/ CH1322935607 /
24/06/2024 09:06:50 | Var.+0.25 | Denaro09:27:59 | Lettera09:27:59 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.97EUR | +14.53% | 1.97 Quantità in denaro: 5,000 |
2.07 Quantità in lettera: 5,000 |
MCDONALDS CORP. DL... | 278.00 - | 16/01/2026 | Call |
GlobeNewswire
09:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
08:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®